NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α NanoTemper’s two strategic milestones – NSM technology acquisition and the launch of Dianthus™ α application – expand its capabilities across the life sciences value chain and enhance support for the discovery of next-generation therapeutics. The Envue Technologies acquisition brings Nanofluidic Scattering […]
CAMBRIDGE, England — Novogene Europe is pleased to announce the launch of its new Whole Plasmid Sequencing service, powered by Oxford Nanopore Technologies (ONT). This service offering represents a major step forward in plasmid verification, providing researchers with a powerful and practical alternative to traditional Sanger sequencing. Unlike conventional approaches, whole plasmid sequencing delivers a […]
– TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. – Preserves DNA integrity in challenging clinically relevant samples, including FFPE tissue and circulating tumor DNA (ctDNA). – Platform-agnostic chemistry enables seamless integration across sequencing systems. BOULDER, Colo. — Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology […]
LONDON, UK — Touchlight, a leader in cell-free DNA technology, today announced the expansion of its groundbreaking mbDNA™ platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA. These innovative constructs join mbDNA, which debuted earlier this year, to form a comprehensive portfolio designed to overcome the limitations of traditional gene editing tools. […]
SAN DIEGO — The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ: ILMN), which had been in place since March 4, 2025. While the ban will be lifted on November 10, Illumina remains on the Unreliable Entities List (UEL), requiring government approval for instrument purchases. Illumina remains focused […]
NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemia MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry Genomics, the Sequel II CNDx system […]
Advanced RNA quantification brings efficiency to assay development PALO ALTO, Calif. – Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings direct counting of RNA to the Countable PCR platform, enabling one-step, bias-free RNA quantification, and delivering the […]
Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market, accelerating growth across its industry-leading Sample technologies portfolio Parse provides Evercode, a highly differentiated instrument-free platform built for analyzing millions and billions of […]
Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux, a world leader in the field of in vitro diagnostics, have announced the launch of AmPORE-TB, a Research Use Only* (RUO) solution for the rapid characterisation of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex, using Oxford Nanopore […]
Oxford, UK – ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ T cell detection are designed to offer researchers unprecedented flexibility, speed, and MHC allele-coverage, with over 50 HLA alleles available. Supplied as highly […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
